Topics for the NCT Trial Center´s newsletter in November 2015 are
• the clinical trials REMOTUX performing in vivo Response Monitoring following antibody treatment and
• N2M2, an umbrella trial for individualized therapy of glioblastomas with unmethylated MGMT promoter based on sequencing data, as well as
• databases developed by the NCT Trial Center for status tracking of complex clinical trials and for sample processing within the DKFZ-HIPO and NCT-POP programs, and
• an addendum of the Guideline for Good Clinical Practice, which is currently under development.
Please follow the links for an English or a German version of the newsletter.